• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home

Press

Home

Press

DNDi’s media team welcomes inquiries from journalists, academia, and the general public. You can contact us at media@dndi.org. 

Would you like to receive our news and press releases in your inbox as soon as they are published? Please send us an email and we will add you to our media directory. 

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2025

Results

No results found. Please try using different filter option(s).

News
4 Dec 2025

Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi

Press releases
27 Nov 2025

International seminar explores the development of treatments for dengue for populations not covered by vaccines

News
26 Nov 2025

DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment

Dr Pauline Williams
Videos
24 Nov 2025

Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair

Scientific articles
20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers
Viewpoints
20 Nov 2025

Neglecting infectious diseases is a market failure

Financial Times
Videos
20 Nov 2025

Beni: Surviving Sleeping Sickness

Publications
17 Nov 2025

Open Science in a Closed World

News
17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations 

In the media
16 Nov 2025

Fra flue til flue har denne fjende hærget Afrika. Men nu er sejren mod sovesyge lige om hjørnet

Verdens Bedste Nyheder
Statements
13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

EFE logo
In the media
12 Nov 2025

Varios activistas climáticos invaden el área restringida de la COP30 durante una protesta

EFE
The British Medical Journal logo
In the media
11 Nov 2025

Policies to promote affordability and access across the life cycle of costly new drugs

The BMJ
Press releases
10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

New Vision logo
In the media
7 Nov 2025

Hope for millions as over sh180b invested to develop new drugs for dengue fever

New Vision
AFP logo
In the media
4 Nov 2025

Dengue : l’Europe investit 20 millions d’euros pour développer de nouveaux traitements

AFP
loading

Press Releases

Loading…
filter by
Press releases
Press Releases Translations
Press releases
27 Nov 2025

International seminar explores the development of treatments for dengue for populations not covered by vaccines

Press releases
10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

Press releases
4 Nov 2025

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

Press releases
23 Sep 2025

Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral 

see ALL

In the Media

Loading…
In the media
16 Nov 2025

Fra flue til flue har denne fjende hærget Afrika. Men nu er sejren mod sovesyge lige om hjørnet

Verdens Bedste Nyheder
EFE logo
In the media
12 Nov 2025

Varios activistas climáticos invaden el área restringida de la COP30 durante una protesta

EFE
The British Medical Journal logo
In the media
11 Nov 2025

Policies to promote affordability and access across the life cycle of costly new drugs

The BMJ
New Vision logo
In the media
7 Nov 2025

Hope for millions as over sh180b invested to develop new drugs for dengue fever

New Vision
see ALL

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Linkedin Instagram X-twitter Facebook Youtube
EM PORTUGUÊS
EN ESPAÑOL
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license